Translational suppression of calpain blocks long-term potentiation

Learning Memory

Volumn 3, Issue 2-3, 1996, Pages 209-217

  Vanderklish, Peter ^a   Bednarski, Eric ^a   Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALPAIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; SYNAPSE;

EID: 0029962597     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.3.2-3.209     Document Type: Article

References (47)

1. 2+-activated neutral protease (μCANP) deduced from its cDNA sequence. FEBS Lett 205: 313-317.
2. Bahr, B.A. 1995. Long-term hippocampal slices: A model system for investigating synaptic mechanisms and pathological processes. J. Neurosci Res. 42: 294-305.
3. Bahr, B.A., B. Abai, C.M. Gall, P.W. Vanderklish, K B. Huffman, and G. Lynch. 1994. Induction of β-Amyloid-containing polypeptides in hippocampus: Evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129:81-94.
4. Bahr, B A., S. Tiriveedhi, G.Y Park, and G. Lynch. 1995. Induction of calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. J Pharmacol. Exp. Ther. 273: 902-908.
5. Bednarski, E., P. Vanderklish, C. Gall, T.C. Saido, B.A. Bahr, and G. Lynch. 1995 Translational suppression of calpain I reduces NMDA-induced spectrin proteolysis and pathophysiology in cultured hippocampal slices. Brain Res. 694: 147-157.
6. Bliss, T V.P. and G.L. Collingridge. 1993. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361: 31-39.
7. Bliss, T.V.P. and T. Lomo. 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 232: 331-356.
8. Bradford, M. 1976. A rapid and sensitive method for the detection and quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 421: 167-172.
9. Buchs, P.-A., L. Stoppini, and D. Muller. 1993. Structural modifications associated with synaptic development in area CA1 of rat hippocampal organotypic cultures. Dev. Brain Res. 71: 81-91.
10. Carlin, R.K., D.C. Bartelt, and P. Siekevitz. 1983. Identification of fodrin as a major calmodulin-binding protein in postsynaptic density preparations. J. Cell Biol. 96: 443-448.
11. Covault, J., Q.Y. Lui, and S. el-Deeb. 1991. Calcium-activated proteolysis of intracellular domains in the cell adhesion molecules NCAM and N-cadherin. Mol. Brain Res. 11: 11-16.
12. Croall, D.E. and G.N. DeMartino. 1991. Calcium-activated neutral protease (calpain) system: Structure, function, and regulation Physiol. Rev. 71: 813-847.
13. del Cerro, S , J. Larson, M.W. Oliver, and G. Lynch. 1990. Development of hippocampal long-term potentiation is reduced by recently introduced calpain inhibitors. Brain Res. 530: 91-95.
14. Denny, J.B , J. Polan-Curtain, A. Ghuman, M.J. Wayner, and D.L. Armstrong. 1990. Calpain inhibitors block long-term potentiation. Brain Res. 534: 317-320.
15. Dosemeci, A. and T.S. Reese. 1995. Effect of calpain on the composition and structure of postsynaptic densities. Synapse 20: 91-97.
16. Emori, Y., H. Kawasaki, H. Sugihara, S. Imajoh, S. Kawashima, and S. Suzuki. 1986. Isolation and sequence analysis of cDNA clones for the large subunits of two isozymes of rabbit calcium-dependent protease. J. Biol. Chem. 261: 9465-9471.
17. Fukuda, T., E. Adachi, S. Kawashima, I Yoshiya, and P.H. Hashimoto. 1990. Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rat hippocampus J. Comp. Neurol. 302: 100-109.
18. Guthrie, P.E., S. Menahem, and S.B. Kater 1991. Independent regulation of calcium revealed by imaging dendritic spines. Nature 354: 76-79.
19. Hall, R , M. Kessler, and G. Lynch. 1992. Evidence that high- and low-affinity DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) binding sites reflect membrane-dependent states of a single receptor. J. Neurochem. 59: 1997-2004.
20. Ivy, G.O., P. Seubert, M. Baudry, and G Lynch. 1988. Presence of brain spectrin in dendrites of mammalian brain: Technical factors involved in immunocytochemical detection. Synapse 2: 329-333.
21. Larson, J. and G. Lynch. 1986. Induction of synaptic potentiation in hippocampus by patterned stimulation involves two events. Science 232: 985-988.
22. Luthi, A., J.P. Laurent, A. Figurov, D. Muller, and M. Shachner. 1994. Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM. Nature 372: 777-779.
23. Lynch, G., B.A. Bahr, and P.W. Vanderklish. 1991 a. Induction and stabilization of long-term potentiation. In Glutamate, cell death and memory (ed. P. Ascher, D.W. Choi, and Y. Christen), pp. 45-60. Springer-Verlag, Berlin, Germany.
24. Lynch, G., J. Larson, U. Staubli, R. Granger. 1991b. Relating variants of synaptic potentiation to different types of memory operations in hippocampus and related structures In Memory. Organization and locus of change (ed. L.R. Squire, N.M. Weinberger, G. Lynch, and J.L McGaugh), pp. 339-363. Oxford University Press, New York, NY.
25. 2: A necessary step in long-term potentiation? Proc. Natl. Acad. Sci. 88: 1893-1897.
26. Milligan, J.F., M.D. Matteucci, and J.C. Martin. 1993. Current concepts in antisense drug design. J. Med. Chem. 36: 1923-1937.
27. Muller, D., P.-A. Buchs, and L. Stoppini, 1993. Time course of synaptic development in hippocampal organotypic cultures. Dev Brain Res. 71: 93-100.
28. Muller, D., I. Molinari, L. Soldati, G. Bianchi. 1995. A genetic deficiency in calpastatin and isovalerylcarnitine treatment is associated with enhanced hippocampal long-term potentiation. Synapse 19: 37-45.
29. 2+ responses. Nature 354: 73-76.
30. Perlmutter, L.S., C Gall, M. Baudry, and G Lynch. 1990. Distribution of calcium-activated protease calpain in rat brain. J. Comp. Neurol. 296: 269-276.
31. Peterson, C., P. Vanderklish, P Seubert, C Cotman, and G. Lynch. 1991. Increased spectrin proteolysis in fibroblasts from aged and Alzheimer donors. Neurosci. Lett. 121: 239-243.
32. 2+ transients in dendritic spines of hippocampal pyramidal neurons in brain slice. Neuron 14: 1223-1231.
33. Roberts-Lewis, J.M., M.J. Savage, V.R. Marcy, L.R. Pinsker, and R. Siman. 1994. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14: 3934-3944.
34. Ronn, L.C., E. Bock, D. Linnemann, and H. Jahnsen. 1995. NCAM-antibodies modulate induction of long-term potentiation in rat hippocampal CA1. Brain Res 677: 145-151.
35. Saido, T.C., M. Yokota, S. Nagao, I. Yamaura, E. Tani, T. Tsuchiya, K. Suzuki, S. Kawashima. 1993. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268: 25239-25243.
36. Saido, T.C-, H. Sorimachi, and K. Suzuki. 1994. Calpain: New perspectives in molecular diversity and physiological-pathophysiological involvement. FASEB I 8: 814-822.
37. Sheppard, A., J. Wu, U. Rutishauser, and G. Lynch. 1991 Proteolytic modification of neural cell adhesion molecule (N-CAM) by the intracellular proteinase calpain. Biochem. Biophys. Acta 1076: 156-160.
38. Siman, R., M. Baudry, and C. Lynch. 1984. Brain fodrin: Substrate for the endogenous calcium-activated protease, calpain 1. Proc. Natl Acad. Sci. 81: 3276-3280.
39. Siman, R., C. Gall, L.S. Perlmutter, and G. Lynch. 1985. Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain. Brain Res. 347: 399-403.
40. Staubli, U., J. Larson, O. Thibault, M. Baudry, and G. Lynch. 1988. Chronic administration of a thiol-proteinase inhibitor blocks long-term potentiation of synaptic responses. Brain Res. 444: 153-158.
41. Staubli, U., P Vanderklish, and G. Lynch. 1991. An inhibitor of integrin receptors blocks long-term potentiation. Behav. Neurol. Biol. 53: 1-5.
42. Stoppini, L., P.-A. Buchs, and D. Muller. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci. Methods 37: 173-182.
43. 3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes. Mol. Pharmacol. 34: 117-123.
44. Teyler, T.J. and P DiScenna. 1984. Long-term potentiation as a candidate mnemonic device. Brain Res. Rev. 7: 15-28.
45. Vanderklish, P., R. Neve, B.A. Bahr, A. Arai, M. Hennegriff, J. Larson, and G. Lynch. 1992. Translational suppression of a glutamate receptor subunit impairs long-term potentiation. Synapse 12: 333-337.
46. Vanderklish, P., T.C. Saido, C. Gall, A. Arai, and G. Lynch. 1995 Proteolysis of spectrin by calpain accompanies theta-burst stimulation in cultured hippocampal slices. Mol. Brain Res 32: 25-35.
47. Xiao, P., B.A. Bahr, U. Staubli, P.W. Vanderklish, and G. Lynch. 1991. Evidence that matrix recognition contributes to stabilization but not induction of LTP. NeuroReport 2: 461-464.